| Year |
Citation |
Score |
| 2023 |
Rolband L, Godakhindi V, Vivero-Escoto JL, Afonin KA. Demonstrating the Synthesis and Antibacterial Properties of Nanostructured Silver. Journal of Chemical Education. 100: 3547-3555. PMID 37720521 DOI: 10.1021/acs.jchemed.3c00125 |
0.324 |
|
| 2023 |
Huq TB, Vivero-Escoto JL. Synthesis of Mesoporous Silica Nanoparticles for the Delivery of Nucleic Acid Nanostructures. Methods in Molecular Biology (Clifton, N.J.). 2709: 205-210. PMID 37572282 DOI: 10.1007/978-1-0716-3417-2_13 |
0.477 |
|
| 2023 |
Vadarevu H, Sorinolu AJ, Munir M, Vivero-Escoto JL. Autophagy Regulation Using Multimodal Chlorin e6-Loaded Polysilsesquioxane Nanoparticles to Improve Photodynamic Therapy. Pharmaceutics. 15. PMID 37242794 DOI: 10.3390/pharmaceutics15051548 |
0.355 |
|
| 2022 |
Sorinolu AJ, Godakhindi V, Siano P, Vivero-Escoto JL, Munir M. Influence of silver ion release on the inactivation of antibiotic resistant bacteria using light-activated silver nanoparticles. Materials Advances. 3: 9090-9102. PMID 36545324 DOI: 10.1039/d2ma00711h |
0.333 |
|
| 2022 |
Tarannum M, Vivero-Escoto JL. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment. Advanced Drug Delivery Reviews. 114357. PMID 35605679 DOI: 10.1016/j.addr.2022.114357 |
0.353 |
|
| 2022 |
Tarannum M, Holtzman K, Dréau D, Mukherjee P, Vivero-Escoto JL. Nanoparticle combination for precise stroma modulation and improved delivery for pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 347: 425-434. PMID 35569588 DOI: 10.1016/j.jconrel.2022.05.019 |
0.37 |
|
| 2021 |
Loman-Cortes P, Binte Huq T, Vivero-Escoto JL. Use of Polyhedral Oligomeric Silsesquioxane (POSS) in Drug Delivery, Photodynamic Therapy and Bioimaging. Molecules (Basel, Switzerland). 26. PMID 34770861 DOI: 10.3390/molecules26216453 |
0.367 |
|
| 2021 |
Tarannum M, Hossain MA, Holmes B, Yan S, Mukherjee P, Vivero-Escoto JL. Advanced Nanoengineering Approach for Target-Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine-Cisplatin Combination for Improved Therapeutic Outcome in Pancreatic Cancer. Small (Weinheim An Der Bergstrasse, Germany). e2104449. PMID 34758094 DOI: 10.1002/smll.202104449 |
0.414 |
|
| 2021 |
Vadarevu H, Juneja R, Lyles Z, Vivero-Escoto JL. Light-Activated Protoporphyrin IX-Based Polysilsesquioxane Nanoparticles Induce Ferroptosis in Melanoma Cells. Nanomaterials (Basel, Switzerland). 11. PMID 34578640 DOI: 10.3390/nano11092324 |
0.445 |
|
| 2020 |
Juneja R, Vadarevu H, Halman J, Tarannum M, Rackley L, Dobbs J, Marquez J, Chandler M, Afonin KA, Vivero-Escoto JL. Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance In Vitro. Acs Applied Materials & Interfaces. PMID 32805923 DOI: 10.1021/Acsami.0C07106 |
0.537 |
|
| 2020 |
Alvarez-Berrios MP, Aponte-Reyes LM, Diaz-Figueroa L, Vivero-Escoto J, Johnston A, Sanchez-Rodriguez D. Preparation and In Vitro Evaluation of Alginate Microparticles Containing Amphotericin B for the Treatment of Infections. International Journal of Biomaterials. 2020: 2514387. PMID 32802065 DOI: 10.1155/2020/2514387 |
0.451 |
|
| 2019 |
Vivero-Escoto JL, Vadarevu H, Juneja R, Schrum LW, Benbow JH. Nanoparticle mediated silencing of tenascin C in hepatic stellate cells: effect on inflammatory gene expression and cell migration. Journal of Materials Chemistry. B. PMID 31701111 DOI: 10.1039/C9Tb01845J |
0.386 |
|
| 2019 |
Juneja R, Lyles Z, Vadarevu H, Afonin KA, Vivero-Escoto JL. Multimodal Polysilsesquioxane Nanoparticles for Combinatorial Therapy and Gene Delivery in Triple-Negative Breast Cancer. Acs Applied Materials & Interfaces. PMID 30844224 DOI: 10.1021/Acsami.9B00704 |
0.537 |
|
| 2018 |
Alvarez-Berrios MP, Aponte-Reyes LM, Aponte-Cruz LM, Loman-Cortes P, Vivero-Escoto JL. Effect of the surface charge of silica nanoparticles on oil recovery: wettability alteration of sandstone cores and imbibition experiments International Nano Letters. 8: 181-188. DOI: 10.1007/S40089-018-0243-5 |
0.356 |
|
| 2017 |
Vivero-Escoto JL, Vega DL. Target-specific porphyrin-loaded hybrid nanoparticles to improve photodynamic therapy for cancer treatment Proceedings of Spie. 10047: 1004713. DOI: 10.1117/12.2252618 |
0.533 |
|
| 2017 |
Vivero-Escoto JL, Jeffords LM, Dréau D, Alvarez-Berrios M, Mukherjee P. Mucin1 antibody-conjugated dye-doped mesoporous silica nanoparticles for breast cancer detection in vivo Proceedings of Spie. 10078. DOI: 10.1117/12.2252369 |
0.413 |
|
| 2016 |
Dréau D, Moore LJ, Alvarez-Berrios MP, Tarannum M, Mukherjee P, Vivero-Escoto JL. Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model. Journal of Biomedical Nanotechnology. 12: 2172-2184. PMID 28522938 DOI: 10.1166/Jbn.2016.2318 |
0.423 |
|
| 2016 |
Alvarez-Berríos MP, Vivero-Escoto JL. In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin. International Journal of Nanomedicine. 11: 6251-6265. PMID 27920531 DOI: 10.2147/Ijn.S118196 |
0.594 |
|
| 2016 |
Cepeda-Pérez E, López-Luke T, Salas P, Plascencia-Villa G, Ponce A, Vivero-Escoto J, José-Yacamán M, de la Rosa E. SERS-active Au/SiO2 clouds in powder for rapid ex vivo breast adenocarcinoma diagnosis. Biomedical Optics Express. 7: 2407-18. PMID 27375955 DOI: 10.1364/Boe.7.002407 |
0.409 |
|
| 2016 |
Walker WA, Tarannum M, Vivero-Escoto JL. Cellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica Nanoparticles. Journal of Materials Chemistry. B, Materials For Biology and Medicine. 4: 1254-1262. PMID 27134749 DOI: 10.1039/C5Tb02079D |
0.565 |
|
| 2016 |
Cepeda-Pérez E, López-Luke T, Plascencia-Villa G, Perez-Mayen L, Ceja-Fdez A, Ponce A, Vivero-Escoto J, de la Rosa E. SERS and integrative imaging upon internalization of quantum dots into human oral epithelial cells. Journal of Biophotonics. PMID 27120043 DOI: 10.1002/Jbio.201600034 |
0.397 |
|
| 2016 |
Vega DL, Lodge P, Vivero-Escoto JL. Redox-Responsive Porphyrin-Based Polysilsesquioxane Nanoparticles for Photodynamic Therapy of Cancer Cells. International Journal of Molecular Sciences. 17. PMID 26729110 DOI: 10.3390/Ijms17010056 |
0.494 |
|
| 2016 |
Alvarez-Berríos MP, Sosa-Cintron N, Rodriguez-Lugo M, Juneja R, Vivero-Escoto JL. Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments Journal of Chemistry. 2016: 1-15. DOI: 10.1155/2016/2672740 |
0.538 |
|
| 2015 |
Vivero-Escoto JL, Elnagheeb M. Mesoporous Silica Nanoparticles Loaded with Cisplatin and Phthalocyanine for Combination Chemotherapy and Photodynamic Therapy in vitro. Nanomaterials (Basel, Switzerland). 5: 2302-2316. PMID 28347122 DOI: 10.3390/Nano5042302 |
0.523 |
|
| 2015 |
Ceja-Fdez A, López-Luke T, Oliva J, Vivero-Escoto J, Gonzalez-Yebra AL, Rojas RA, Martínez-Pérez A, de la Rosa E. Labeling of HeLa cells using ZrO2:Yb(3+)-Er(3+) nanoparticles with upconversion emission. Journal of Biomedical Optics. 20: 046006. PMID 25879389 DOI: 10.1117/1.Jbo.20.4.046006 |
0.502 |
|
| 2015 |
Rocca JD, Werner ME, Kramer SA, Huxford-Phillips RC, Sukumar R, Cummings ND, Vivero-Escoto JL, Wang AZ, Lin W. Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 31-8. PMID 25038495 DOI: 10.1016/J.Nano.2014.07.004 |
0.414 |
|
| 2015 |
Cepeda-Pérez EI, López-Luke T, Pérez-Mayen L, Hidalgo A, De La Rosa E, Torres-Castro A, Ceja-Fdez A, Vivero-Escoto J, Gonzalez-Yebra AL. Wet chemical synthesis of quantum dots for medical applications Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9537. DOI: 10.1117/12.2183183 |
0.384 |
|
| 2015 |
Vivero-Escoto JL, Vega DL. Stimuli-responsive protoporphyrin IX silica-based nanoparticles to improve photodynamic therapy in vitro Photodiagnosis and Photodynamic Therapy. 12: 360. DOI: 10.1016/J.Pdpdt.2015.07.137 |
0.496 |
|
| 2015 |
Vivero-Escoto JL, Lyles Z, Vega DL. Multifunctional porphyrin-based polysilsesquioxane nanoparticles with improved loading capacity and phototherapeutic effect Photodiagnosis and Photodynamic Therapy. 12: 340. DOI: 10.1016/J.Pdpdt.2015.07.062 |
0.533 |
|
| 2014 |
Vivero-Escoto JL, DeCillis D, Fritts L, Vega DL. Porphyrin-based polysilsesquioxane nanoparticles to improve photodynamic therapy for cancer treatment Proceedings of Spie. 8931. DOI: 10.1117/12.2039145 |
0.546 |
|
| 2014 |
Vivero-Escoto JL, Vega DL. Stimuli-responsive protoporphyrin IX silica-based nanoparticles for photodynamic therapy in vitro Rsc Adv.. 4: 14400-14407. DOI: 10.1039/C4Ra01135J |
0.553 |
|
| 2013 |
Vivero-Escoto JL, Rieter WJ, Lau H, Huxford-Phillips RC, Lin W. Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging. Small (Weinheim An Der Bergstrasse, Germany). 9: 3523-31. PMID 23613450 DOI: 10.1002/Smll.201300198 |
0.358 |
|
| 2012 |
Vivero-Escoto JL, Chiang YD, Wu K, Yamauchi Y. Recent progress in mesoporous titania materials: adjusting morphology for innovative applications. Science and Technology of Advanced Materials. 13: 013003. PMID 27877467 DOI: 10.1088/1468-6996/13/1/013003 |
0.437 |
|
| 2012 |
Vivero-Escoto JL, Huxford-Phillips RC, Lin W. Silica-based nanoprobes for biomedical imaging and theranostic applications. Chemical Society Reviews. 41: 2673-85. PMID 22234515 DOI: 10.1039/C2Cs15229K |
0.529 |
|
| 2011 |
Vivero-Escoto JL, Taylor-Pashow KM, Huxford RC, Della Rocca J, Okoruwa C, An H, Lin W, Lin W. Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance. Small (Weinheim An Der Bergstrasse, Germany). 7: 3519-28. PMID 22069305 DOI: 10.1002/Smll.201100521 |
0.324 |
|
| 2011 |
Vivero-Escoto JL, Huang YT. Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications. International Journal of Molecular Sciences. 12: 3888-927. PMID 21747714 DOI: 10.3390/Ijms12063888 |
0.414 |
|
| 2011 |
Tsai CH, Vivero-Escoto JL, Slowing II, Fang IJ, Trewyn BG, Lin VS. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles. Biomaterials. 32: 6234-44. PMID 21684000 DOI: 10.1016/J.Biomaterials.2011.04.077 |
0.8 |
|
| 2011 |
Slowing II, Vivero-Escoto JL, Zhao Y, Kandel K, Peeraphatdit C, Trewyn BG, Lin VS. Exocytosis of mesoporous silica nanoparticles from mammalian cells: from asymmetric cell-to-cell transfer to protein harvesting. Small (Weinheim An Der Bergstrasse, Germany). 7: 1526-32. PMID 21520497 DOI: 10.1002/Smll.201002077 |
0.761 |
|
| 2011 |
Slowing II, Vivero-Escoto JL, Zhao Y, Kandel K, Peeraphatdit C, Trewyn BG, Lin VS. Drug Delivery: Exocytosis of Mesoporous Silica Nanoparticles from Mammalian Cells: From Asymmetric Cell-to-Cell Transfer to Protein Harvesting (Small 11/2011) Small. 7: 1498-1498. DOI: 10.1002/Smll.201190039 |
0.801 |
|
| 2010 |
Zhao Y, Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery. Expert Opinion On Drug Delivery. 7: 1013-29. PMID 20716017 DOI: 10.1517/17425247.2010.498816 |
0.776 |
|
| 2010 |
Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small (Weinheim An Der Bergstrasse, Germany). 6: 1952-67. PMID 20690133 DOI: 10.1002/Smll.200901789 |
0.811 |
|
| 2010 |
Vivero-Escoto JL, Slowing II, Lin VS. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials. 31: 1325-33. PMID 19932923 DOI: 10.1016/J.Biomaterials.2009.11.009 |
0.781 |
|
| 2010 |
Slowing II, Vivero-Escoto JL, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles: Structural design and applications Journal of Materials Chemistry. 20: 7924-7937. DOI: 10.1039/C0Jm00554A |
0.764 |
|
| 2009 |
Mortera R, Vivero-Escoto J, Slowing II, Garrone E, Onida B, Lin VS. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. Chemical Communications (Cambridge, England). 3219-21. PMID 19587919 DOI: 10.1039/B900559E |
0.82 |
|
| 2009 |
Vivero-Escoto JL, Slowing II, Wu CW, Lin VS. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. Journal of the American Chemical Society. 131: 3462-3. PMID 19275256 DOI: 10.1021/Ja900025F |
0.799 |
|
| 2009 |
Slowing II, Wu CW, Vivero-Escoto JL, Lin VS. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small (Weinheim An Der Bergstrasse, Germany). 5: 57-62. PMID 19051185 DOI: 10.1002/Smll.200800926 |
0.774 |
|
| 2008 |
Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Advanced Drug Delivery Reviews. 60: 1278-88. PMID 18514969 DOI: 10.1016/J.Addr.2008.03.012 |
0.811 |
|
| Show low-probability matches. |